Projekt

SAKK 21/18 Ribociclib-endocrine combination therapy versus chemotherapy as 1st line treatment in patients with visceral metastatic breast cancer. A mul-ticenter, randomized phase III trial

Laufend - Rekrutierung – laufend · 2019 bis 2026

Hasler-Strub Ursula